Retatrutide — Triple Agonist Peptide
 
Retatrutide is one of the most advanced research peptides available. It's called a "triple agonist" because it simultaneously activates three receptors:
 
Receptor
Role
GLP-1
Reduces appetite, regulates blood sugar
GIP
Enhances insulin response, fat metabolism
Glucagon
Boosts energy expenditure, burns fat


🔬 What it's studied for:
Weight loss — considered more potent than Semaglutide or Tirzepatide in research trials
Metabolic health — improves insulin sensitivity and blood sugar regulation
Fat reduction — targets visceral (belly) fat directly
Liver health — studied for non-alcoholic fatty liver disease (NAFLD)
Cardiovascular benefits — may reduce cardiovascular risk markers